GLP-1R in diabetes mellitus: from basic discovery to therapeutics development
Diabetes mellitus (DM), a metabolic disorder syndrome characterized by persistent hyperglycemia, has a complex pathogenesis. As the number of diabetic patients continues to grow globally, this disease has become a major and growing challenge in global public health. Glucagon-like peptide-1 receptor...
Saved in:
| Main Authors: | Shujun Li, Nanqu Huang, Mei Wang, Wendi Huang, Yong Luo, Juan Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1610512/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GLP-1R as a potential link between diabetes and Alzheimer’s disease
by: Shujun Li, et al.
Published: (2025-07-01) -
Current and potential use of GLP-1R agonists: beyond type 2 diabetes
by: Graciela Zambrano-Galván, et al.
Published: (2024-10-01) -
GLP-1 and Its Role in Glycogen Production: A Narrative Review
by: Joseph Lotosky, et al.
Published: (2025-06-01) -
Impact of GLP-1 Receptor Agonists on Perceived Eating Behaviors in Response to Stimuli
by: Cheney C, et al.
Published: (2025-05-01) -
Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease
by: Melinda Urkon, et al.
Published: (2025-04-01)